##  [What is DICOL? Understanding Brazil’s Regulatory Authority](/what-is-dicol-understanding-brazils-regulatory-authority) 

1 min read 

  Your browser does not support the audio element.





## Introduction

DICOL, the **Collegiate Board of Directors** of **ANVISA** (Agência Nacional de Vigilância Sanitária), oversees pharmaceutical regulations, medical devices, and public health policies in Brazil. It plays a crucial role in approving Regulatory resolutions, ensuring compliance, and expediting market access for healthcare products.

## Key Responsibilities of DICOL

**1. Regulatory Decision-Making**

DICOL enforces RDCs (Resoluções da Diretoria Colegiada) covering:

- Pharmaceutical approvals
- Medical device regulations
- Clinical trials and food safety

**2. CADIFA Certification**

DICOL oversees CADIFA (Certificate of Suitability of Active Pharmaceutical Ingredient Dossier), ensuring API manufacturers comply with Brazilian Regulatory standards.

**3. Regulatory Reliance & Global Alignment**

DICOL fast-tracks approvals by recognizing assessments from agencies like the FDA, EMA, and TGA, reducing market entry barriers.

**4. Post-Market Surveillance**

DICOL enforces pharmacovigilance, device monitoring, and recalls, safeguarding product quality and patient safety.

**Impact on Brazil’s Healthcare Industry**

DICOL’s Regulatory oversight ensures:

- High-quality pharmaceuticals & medical devices
- Accelerated market entry for global companies
- Regulatory harmonization with international standards
- Robust public health protection

DICOL plays a pivotal role in Brazil’s pharmaceutical and medical device Regulatory landscape, supporting compliance, market expansion, and patient safety.

Looking to navigate Brazil’s complex Regulatory environment? Our Regulatory experts can help you ensure smooth market entry and compliance. [Contact Us](javascript:void(0))  today to streamline your approvals.